Stock Price
5.51
Daily Change
-0.29 -5.00%
Monthly
-10.99%
Yearly
131.51%
Q2 Forecast
5.81

Silence Therapeutics reported $-11.77M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AstraZeneca USD 2.33B 207M Dec/2025
Autolus Therapeutics Ltd USD -90.33M 11.21M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Silence Therapeutics USD -11.77M 9.19M Dec/2025